SARAH INGALSBE-GENO: Open Payments
NPI 1942290184 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 27 payments from 17 companies in 2025. Trend: 2023 $168 · 2024 $521 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| Amgen Inc. | 4 | $71 |
| Lilly USA, LLC | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Verona Pharma, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
Products named: TRELEGY ELLIPTA, CREON, MOUNJARO, EVENITY, XIFAXAN, VRAYLAR, CAPLYTA, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
